欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号EE/H/0318/001
药品名称Urapidil Kalceks
活性成分
    • urapidil 25.0 mg
剂型Solution for injection/infusion
上市许可持有人AS KALCEKS Krustpils iela 53, Riga,LV-1057, Latvia
参考成员国 - 产品名称Estonia (EE)
互认成员国 - 产品名称
    • Austria (AT)
      Urapidil Kalceks 25 mg Injektions-/Infusionslösung
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Urapidil KALCEKS
    • Slovenia (SI)
    • Latvia (LV)
      Urapidil Kalceks 25 mg šķīdums injekcijām/infūzijām
    • Croatia (HR)
    • Hungary (HU)
    • Czechia (CZ)
      Urapidil Kalceks
    • Romania (RO)
      Urapidil Kalceks 25 mg/ml soluție injectabilă/perfuzabilă
    • Slovakia (SK)
      Urapidil Kalceks 25 mg injekčný/infúzny roztok
    • Germany (DE)
      Urapidil Kalceks
    • Netherlands (NL)
许可日期2021/02/08
最近更新日期2023/12/08
药物ATC编码
    • C02CA06 urapidil
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase